Home/Filings/4/0001209191-22-011724
4//SEC Filing

Quinn Anthony G. 4

Accession 0001209191-22-011724

CIK 0001636282other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:57 PM ET

Size

5.6 KB

Accession

0001209191-22-011724

Insider Transaction Report

Form 4
Period: 2022-02-17
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-17+350,000350,000 total
    Exercise: $3.17Exp: 2032-02-16Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 17, 2022, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0001532219

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:57 PM ET
Size
5.6 KB